Glutathione (GSH) plays an important role in protecting cells against injury, particularly during oxidative stress. Alterations in GSH metabolism are becoming the focus of attention in many diseases such as cancer, neurodegeneration, and AIDS. As such, a rapid assessment of GSH levels in a clinical setting is of increasing importance. We tested the efficacy of the thiol-labeling fluorescent dye CM-SNARF in its ability to measure variations in GSH concentration using a visible-light flow cytometer. GSH levels in I83, Jurkat, and primary lymphocytes were depleted with buthionine sulfoximine (BSO) or diamide, or increased with N-acetylcysteine (NAC). Following each treatment, cells were divided and either labeled with CM-SNARF followed by flow cytometry analysis, or assayed for GSH using a biochemical method. BSO treatment caused a maximal 87-90% decrease in GSH and 68-76% decrease in fluorescence units. Diamide depleted GSH 91-95%, corresponding to a fluorescence decrease of 85-88%. NAC treatment increased GSH levels 27% and fluorescence 12-19%. The overall correlation (R 2 ) between mean GSH concentration and mean fluorescence was 0.80-0.88. CM-SNARF can be used to semi-quantitatively and rapidly determine intracellular variations in GSH concentration in the range of 10-150 nmoles GSH/mg protein. '
2007International Society for Analytical Cytology Key terms glutathione (GSH); flow cytometry; 5-(and-6)-chloromethyl SNARF-1 acetate; buthionine sulfoximine (BSO); diamide; primary lymphocytes; N-acetylcysteine GLUTATHIONE (GSH) is a major intracellular antioxidant and plays an important role in several cellular processes including the maintenance of redox potential, amino acid transport, and the protection of cells from damage by free radicals, peroxides, and toxins (1). Disturbances within the GSH system, resulting in decreased cellular GSH, have been documented in many conditions including Alzheimer's (2,3) and Parkinson's (4) diseases, schizophrenia (5-7), and AIDS (8). Conversely, increased tumor GSH can be associated with chemotherapy drug resistance (9-13). Some reports have shown that peripheral erythrocyte GSH levels and glutathione-S-transferase (GST) activity positively correlate with tumor levels and activity and chemotherapeutic response (14), while other reports have shown that increasing GSH levels via the administration of thiol compounds can help to diminish the level of GSH depletion associated with the use of some chemotherapeutic agents, thus offering a cytoprotective effect (15,16). Collectively, these reports suggest that the clinical measurement of GSH concentration should prove useful in disease diagnosis and monitoring, especially in terms of cancer management where patient GSH levels may influence the choice and dosing of chemotherapy regimens. As a result, the ability to rapidly measure GSH concentrations in clinical samples is of increasing importance.